Skip to main content
Vetoquinol SA logo

Vetoquinol SA — Investor Relations & Filings

Ticker · VETO ISIN · FR0004186856 LEI · 969500YP0AETQIK48R39 PA Manufacturing
Open in API
Filings indexed 299 across all filing types
Latest filing 2023-03-23 Earnings Release
Country FR France
Listing PA VETO

About Vetoquinol SA

https://www.vetoquinol.com/en

Vetoquinol SA is a global animal health company that researches, develops, produces, and markets veterinary medicines and non-medicinal products. The company provides solutions for both companion animals (cats and dogs) and livestock (cattle and pigs). Its product portfolio addresses a wide range of therapeutic areas, including mobility, dermatology, anti-parasitics, antibiotics, internal medicine, and behavior management. Founded in 1933, the independent, family-owned business focuses on innovation and maintaining a close relationship with veterinary professionals to support animal well-being.

Recent filings

Filing Released Lang Actions
Inside Information / News release on accounts, results
Earnings Release Classification · 100% confidence The document is explicitly titled "2022 ANNUAL RESULTS" and contains comprehensive financial data for the year ended December 31, 2022, including detailed income statements, sales breakdowns by quarter and segment, EBITDA calculation, and management commentary on the full year's performance. This content aligns perfectly with the definition of an Annual Report, which is typically filed on Form 10-K in the US context, or the equivalent comprehensive annual filing. Although it is presented as a press release, the depth and scope of the financial disclosure indicate it is the primary annual results document, making '10-K' the most appropriate classification for a comprehensive annual report, even if the source is a press release summarizing it. It is not merely an Earnings Release (ER) which is usually just highlights, nor is it an Interim Report (IR). FY 2022
2023-03-23 English
Informations privilégiées / Communiqué sur comptes, résultats
Earnings Release Classification · 99% confidence The document is titled "RÉSULTATS ANNUELS 2022" (Annual Results 2022) and contains detailed financial figures for the full fiscal year 2022, including Revenue (Chiffre d'affaires), EBITDA, Net Income (Résultat net), and a simplified income statement (COMPTE DE RÉSULTAT SIMPLIFIÉ) with comparative data from 2021. It also mentions the Board of Directors examined the accounts on March 21, 2023, and proposes a dividend at the upcoming shareholder meeting. This content strongly indicates a comprehensive annual financial disclosure. Although it is not explicitly labeled '10-K' (the US SEC equivalent), in a global context, a comprehensive annual results report detailing the full year's performance aligns best with the definition of an Annual Report (10-K) or a very detailed equivalent. Given the depth of financial tables and the focus on the full year's performance, it is classified as an Annual Report (10-K), as it contains the full annual performance data, not just highlights (ER) or interim data (IR). FY 2022
2023-03-23 French
Inside Information / Other news releases
Regulatory Filings Classification · 99% confidence The document is titled '# PRESS RELEASE' and dated March 6, 2023. It discusses the company's 90th anniversary, its focus areas (antiparasitic, dermatology, mobility, dairy cows), R&D efforts, and mission. It provides contact information for Group Communications and Investor Relations. This content structure strongly suggests a general corporate announcement or news release, rather than a formal regulatory filing like a 10-K, an earnings release (ER) which focuses on quantitative results, or a specific report (AR, IR). Since it is a general press release providing company background and updates, and it doesn't fit neatly into the other specific categories (like DIRS, DIV, CAP, etc.), the most appropriate fallback category is Regulatory Filings (RNS), which often serves as a catch-all for general corporate news releases that are disseminated publicly, especially if they are not explicitly earnings or AGM related.
2023-03-06 English
Informations privilégiées / Autres communiqués
Environmental & Social Information Classification · 99% confidence The document is titled "COMMUNIQUÉ DE PRESSE" (Press Release) dated March 6, 2023. It discusses Vetoquinol celebrating its 90th anniversary, its role in animal health, its R&D efforts, and its mission. It concludes with contact information for Press Relations and Investor Relations, and a brief 'About Vetoquinol' section. This content is characteristic of a general corporate announcement or press release, rather than a formal regulatory filing like a 10-K, an Earnings Release (ER), or a specific financial report (IR, AR). Since it is a general announcement that doesn't fit the specific categories like AGM-R, ER, IR, or DIRS, the most appropriate fallback category is Regulatory Filings (RNS), which serves as a general category for miscellaneous regulatory announcements or press releases that are not explicitly defined elsewhere.
2023-03-06 French
Inside Information / Other news releases
Regulatory Filings Classification · 99% confidence The document is titled 'PRESS RELEASE' and dated January 30th, 2023. It discusses the company's 90th anniversary, its history, management structure (mentioning three generations of the Frechin family), and its current status as a global animal health company. It concludes with contact information for Group Communications and Investor Relations. This content is characteristic of a general corporate announcement or press release intended for the public and investors, often released outside of mandatory periodic financial filings (like 10-K or IR). Since it is a general announcement and does not fit the specific definitions for Earnings Release (ER), Capital Update (CAP), Dividend Notice (DIV), or Management Discussion (MDA), the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous corporate announcements that are not otherwise classified.
2023-01-30 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 85% confidence The document is a corporate communication celebrating the 90th anniversary of Vetoquinol. It provides a historical overview of the company's evolution, its leadership, and its current business strategy. It does not contain financial statements, audit results, or specific regulatory filings, nor is it a report publication announcement. It functions as a general corporate profile or press release regarding the company's history and status, which falls under the 'Regulatory Filings' (RNS) category as a fallback for miscellaneous corporate communications. FY 2023
2023-01-30 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.